Group 1 - The core point of the announcement is that Wang Rong, the vice chairman of Huabang Health, plans to reduce his shareholding by selling up to 2,700,000 shares, which represents 0.1369% of the company's total share capital, within a three-month period from August 19, 2025, to November 18, 2025 [1][2] - As of the announcement date, Wang Rong holds 10,800,000 shares, accounting for 0.5474% of the company's total share capital [1] - The reduction will be conducted through centralized bidding and will not exceed 25% of his total shareholding [1] Group 2 - Wang Rong will comply with relevant regulations, including the Securities Law and the Shenzhen Stock Exchange's self-regulatory guidelines, during the share reduction process [2] - The implementation of the share reduction plan is subject to market conditions and the company's stock price, indicating potential uncertainties regarding the timing and pricing of the sales [2] - The share reduction will not lead to a change in the control of the listed company, nor will it significantly impact the company's governance structure, equity structure, or ongoing operations [2]
华邦健康: 关于公司董事减持股份预披露公告